Aurora Cannabis beats earnings estimates with record revenue and strong cash position

Aurora Cannabis reported quarterly earnings with an EPS of -$0.01, beating analyst estimates of -$0.07, and revenue of $61.09 million, surpassing the expected $54.42 million. The company achieved record annual global medical cannabis net revenue of $288.60 million and a record Adjusted EBITDA of $53.80 million for fiscal 2026. Aurora maintains a strong balance sheet with $164.70 million in cash and no debt, but warns fiscal 2027 will be a "reset year" due to upcoming policy changes. This strong performance highlights Aurora's growth in the global medical cannabis market and its solid financial health going forward.